Literature DB >> 10607500

The ovine cytotoxic T lymphocyte responses to bluetongue virus.

V Janardhana1, M E Andrew, Z I Lobato, B E Coupar.   

Abstract

This study uses recombinant vaccinia viruses expressing truncated or entire bluetongue virus (BTV) proteins to map the location of epitopes recognized by cytotoxic T lymphocytes (CTL) from Australian merino sheep. The non-structural protein, NS1, was recognised by CTL from all sheep, while VP2, VP3, VP5 and VP7 were recognised by CTL from only some sheep. The remaining proteins (except for VP1, which was not tested) did not contain CTL epitopes. When truncated genes were used to map the location of CTL epitopes, it was found that sheep often have CTL that recognise more than one epitope in NS1 or VP2. Overall there was considerable diversity in the CTL recognition patterns in the sheep tested. Copyright 1999 Harcourt Publishers Limited.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10607500     DOI: 10.1053/rvsc.1999.0306

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  13 in total

1.  Purification, stability, and immunogenicity analyses of five bluetongue virus proteins for use in development of a subunit vaccine that allows differentiation of infected from vaccinated animals.

Authors:  Jenna Anderson; Emmanuel Bréard; Karin Lövgren Bengtsson; Kjell-Olov Grönvik; Stéphan Zientara; Jean-Francois Valarcher; Sara Hägglund
Journal:  Clin Vaccine Immunol       Date:  2014-01-22

2.  An updated review on bluetongue virus: epidemiology, pathobiology, and advances in diagnosis and control with special reference to India.

Authors:  Mani Saminathan; Karam Pal Singh; Jaynudin Hajibhai Khorajiya; Murali Dinesh; Sobharani Vineetha; Madhulina Maity; At Faslu Rahman; Jyoti Misri; Yashpal Singh Malik; Vivek Kumar Gupta; Raj Kumar Singh; Kuldeep Dhama
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

3.  Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattle.

Authors:  Jenna Anderson; Sara Hägglund; Emmanuel Bréard; Loic Comtet; Karin Lövgren Bengtsson; John Pringle; Stéphan Zientara; Jean Francois Valarcher
Journal:  Clin Vaccine Immunol       Date:  2013-05-29

4.  Multiserotype protection elicited by a combinatorial prime-boost vaccination strategy against bluetongue virus.

Authors:  Eva Calvo-Pinilla; Nicolás Navasa; Juan Anguita; Javier Ortego
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

5.  Characterization of the immune response induced by a commercially available inactivated bluetongue virus serotype 1 vaccine in sheep.

Authors:  Ana Cristina Pérez de Diego; Pedro José Sánchez-Cordón; Ana Isabel de las Heras; José Manuel Sánchez-Vizcaíno
Journal:  ScientificWorldJournal       Date:  2012-04-24

6.  Expression of VP7, a Bluetongue virus group specific antigen by viral vectors: analysis of the induced immune responses and evaluation of protective potential in sheep.

Authors:  Coraline Bouet-Cararo; Vanessa Contreras; Agathe Caruso; Sokunthea Top; Marion Szelechowski; Corinne Bergeron; Cyril Viarouge; Alexandra Desprat; Anthony Relmy; Jean-Michel Guibert; Eric Dubois; Richard Thiery; Emmanuel Bréard; Stephane Bertagnoli; Jennifer Richardson; Gilles Foucras; Gilles Meyer; Isabelle Schwartz-Cornil; Stephan Zientara; Bernard Klonjkowski
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

7.  Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA).

Authors:  Rachael Chiam; Emma Sharp; Sushila Maan; Shujing Rao; Peter Mertens; Barbara Blacklaws; Nick Davis-Poynter; James Wood; Javier Castillo-Olivares
Journal:  PLoS One       Date:  2009-06-22       Impact factor: 3.240

8.  Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell Responses.

Authors:  Verónica Martín; Elena Pascual; Miguel Avia; Lourdes Peña; Félix Valcárcel; Noemí Sevilla
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240

9.  Ns1 is a key protein in the vaccine composition to protect Ifnar(-/-) mice against infection with multiple serotypes of African horse sickness virus.

Authors:  Francisco de la Poza; Eva Calvo-Pinilla; Elena López-Gil; Alejandro Marín-López; Francisco Mateos; Javier Castillo-Olivares; Gema Lorenzo; Javier Ortego
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

10.  Ovine and murine T cell epitopes from the non-structural protein 1 (NS1) of bluetongue virus serotype 8 (BTV-8) are shared among viral serotypes.

Authors:  José M Rojas; Lourdes Peña; Verónica Martín; Noemí Sevilla
Journal:  Vet Res       Date:  2014-03-12       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.